Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 10, 2013

J&J Innovation, Janssen, and Joslin Diabetes to Pump Up Exercise-Related Targets

  • Joslin Diabetes Center is teaming up with Johnson & Johnson Innovation and its affiliate Janssen Research & Development with the aim of identifing and advancing early-stage, novel therapeutic projects for potential for commercialization and product development. Their first project: identifying exercise-related drug targets for developing new diabetes treatments. 

    This alliance is based on studies by Joslin researchers showing that exercise can train multiple tissues in the body that in turn stimulate metabolic improvements in other tissues. Earlier this year at the American Diabetes Association's Scientific Sessions, Laurie Goodyear, Ph.D., co-head of the Integrative Physiology and Metabolism Section at Joslin and senior investigator on this research, reported that, while the concept of tissue-to-tissue communication is not new, “more recently we have realized that ‘trained’ tissues may communicate to beneficially affect other tissues....Our efforts now are to derive specific factors that help this effect and explore the development into potential therapies for diabetes.”

    "Joslin is uniquely positioned to translate findings in the laboratory into new approaches for treatment of diabetes, and our alliance with Johnson & Johnson Innovation and Janssen Research & Development is an excellent example of how we can move our early discoveries to the clinic with our complementary capabilities," said Nandan Padukone, Ph.D., vp of commercialization and ventures at Joslin, in a statement. 



Related content

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »